Terapias Avanzadas para Tumores Sólidos Pediátricos
Johns Hopkins University School of Medicine
Baltimore, Estados UnidosPublicaciones en colaboración con investigadores/as de Johns Hopkins University School of Medicine (8)
2021
-
Delta-24-RGD, an oncolytic adenovirus, increases survival and promotes proinflammatory immune landscape remodeling in models of AT/RT and CNS-PNET
Clinical Cancer Research, Vol. 27, Núm. 6, pp. 1807-1820
2019
-
The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models
Nature Communications, Vol. 10, Núm. 1
2018
-
Heterogeneity within the PF-EPN-B ependymoma subgroup
Acta Neuropathologica, Vol. 136, Núm. 2, pp. 227-237
2016
-
Analysis of SOX2-regulated transcriptome in glioma stem cells
PLoS ONE, Vol. 11, Núm. 9
-
Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: A retrospective multicohort analysis
Journal of Clinical Oncology, Vol. 34, Núm. 21, pp. 2468-2477
2015
-
Characterization of large structural genetic mosaicism in human autosomes
American Journal of Human Genetics, Vol. 96, Núm. 3, pp. 487-497
2014
-
Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33
Human Molecular Genetics, Vol. 23, Núm. 24, pp. 6616-6633
2012
-
Detectable clonal mosaicism and its relationship to aging and cancer
Nature Genetics, Vol. 44, Núm. 6, pp. 651-658